To the best of our knowledge, direct studies of BA profiles in patients with HD have not yet been reported, although altered total BAs have been shown in a mouse model of the knockout of huntingtin [38], and TUDCA has been applied to HD mice to show neuroprotection effects [53,54,55]. This evidence concerns the gene HTT and Huntington disease.